News Legal Alert life sciences Publications
Tuesday August 16th, 2022
Sorry, this entry is only available in Polish.
Sorry, this entry is only available in Polish.
We have been recommended as one of the best law firms in 14 categories by The Legal500 EMEA 2024 ranking,…
Sołtysiński Kawecki & Szlęzak law firm is currently advising Euricom S.p.A., a prominent global leader in the rice sector, on…
The hemp industry is not only one of the fastest growing in Poland, but also worldwide. New products made with…
We are pleased to announce that our IP team won a Gold Laurel in the ranking of the IAM Patent…
At the end of June, the European Commission (EC) published an updated “Blue Guide”, which, first published in 2000, has…
The hemp market includes food products, cosmetic products, but also pharmaceutical raw materials or products for animals. What should an…
On March 21, 2023, the long-awaited act on clinical trials of medicinal products for human use was signed by the…
On April 10, 2024, the European Parliament adopted an update of four of the seven so-called “breakfast directives”[1] – directives…
The introduction of Regulation (EU) 2017/745 on Medical Devices (“MDR”) gave rise to a number of questions regarding products which…
DISTRIBUTION Possible ’faster’ export/sale of products included on the list of products facing potential shortages in Poland. The Main Pharmaceutical Inspectorate (GIF) will be able…
On the website of the Government Legislation Centre on January 2 this year, a draft act amending the act on…
During a January meeting of the Parliamentary Committee on Economy and Development,[1] the President of the Office of Competition and…
We are pleased to inform that “The Life Sciences Law Review – Edition 6” has been published. Polish chapter authored…
“SK&S’ transaction team has advised AniCura AB in the acquisition process of veterinary clinic “Gliwcka Przychodnia Weterynaryjna”. One of the…
According to the EU Directive, Member States shall ensure that medicinal products which are Over-The-Counter Drug (OTC) are offered for…